沃森:长期研究并未表明性别医疗能预防自杀(文章被护理期刊撤下)

关于跨性别青少年与自杀,事实究竟如何?再审视跨性别青少年自杀的说法

Authors
Jason Watson
Journal
Australian Nursing and Midwifery Journal
Year
2026

Summary

In this short article for an Australian nursing magazine, New Zealand mental health nurse Jason Watson challenges the idea that withholding gender-affirming treatment from young people drives them to suicide. He looks at six large, long-term studies from the Netherlands, Sweden, Denmark, the UK and Finland. In his reading, suicide rates among transgender people stayed well above the general population after treatment, rates fell over time only for trans women in one Dutch study, and the Tavistock clinic review found no rise in youth suicides after access to puberty blockers was restricted in England. He concludes that the 'transition or suicide' claim is weak at best. The article was printed in July 2026, then removed from the journal's website after complaints; the nurses' union apologised for publishing it but later said this did not imply misconduct by the author. It is an opinion piece, not a systematic review: it picks a handful of studies, most of them about adults, and some of its readings go further than the studies' own authors. For example, the Finnish study it relies on most concluded that suicide risk was explained by mental illness and that gender reassignment did not change suicide risk either way.

Key findings

  • 沃森质疑一种被广泛重复的说法,即被拒绝提供性别肯定治疗的年轻人自杀风险更高;WPATH 和美国卫生官员都曾提出这一说法。
  • 他回顾了来自荷兰、瑞典、丹麦、英国和芬兰的六项长期随访研究,样本量从324人到超过15,000人不等,随访时间从5年到46年不等。
  • 他指出,治疗后跨性别者的自杀率和死亡率仍高于一般人群,只有一项荷兰研究发现跨性别女性的自杀率随时间下降。
  • 他重点提到对英格兰塔维斯托克(Tavistock)诊所自杀事件的审查:该审查发现12起自杀,而在青春期阻断剂受到限制后,尽管有人预测自杀会激增,青少年自杀并未增加。
  • 他的结论是,“要么转变性别,要么自杀”的说法“往好了说是站不住脚,往坏了说就是根本错误”,这与卡斯报告(Cass Review)关于该领域大多数研究质量较差的结论一致。
  • 澳大利亚护士工会于2026年7月将该文从期刊网站撤下,并为刊发此文道歉,后来澄清此举并非认定作者存在不当行为。

Abstract

This short article examines the narrative that trans youth who are not provided with gender-affirming healthcare face an increased risk of suicide, a view stated by WPATH's Standards of Care 8 and the US Assistant Secretary for Health in 2022. Noting the Cass Review's finding that research in this field is of poor quality, the author summarises six long-term follow-up studies from the Netherlands (Wiepjes 2020; de Blok 2021), Sweden (Dhejne 2011), Denmark (Erlangsen 2023), England (Appleby 2024, a review of suicides among Tavistock gender clinic patients) and Finland (Ruuska 2024), with sample sizes from 324 to 15,032 and follow-up from five to 46 years, and describes what each reported about suicide and mortality.

Conclusion

Only one finding, the decline in suicide among trans women over time in Wiepjes (2020), appeared to support the narrative that lack of access to gender-affirming care increases suicide risk. The author argues the other studies showed no evidence that treatment reduced suicidal behaviour, and reported higher 'other' mortality after treatment, and that Ruuska (2024), the only study with a matched control group, found much higher suicide and overall mortality among trans people. He concludes the 'trans suicide narrative' is 'at least tenuous and at most simply incorrect', consistent with the Cass Review's view that most research in this field is of poor quality.